NCT01854424View on ClinicalTrials.gov

Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 11, 2016

Conditions
Acute Respiratory Distress Syndrome (ARDS)Mechanical Ventilation
Interventions
OTHER

Bronchoalveolar lavage (BAL) before day 2 , between days 5-7 and days 10-14 of evolution.

All the samples will be obtained during current care in the first week of evolution, and the last set of samples (BAL and blood sample between day 10-14) only in patients still under ventilation at this time point.

Trial Locations (1)

75970

Hôpital TENON, département d'anesthésie-réanimation, Paris

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01854424 - Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS | Biotech Hunter | Biotech Hunter